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Abstract 
The Conoidea superfamily, comprised of cone snails, terebrids, and turrids, is an 
exceptionally promising group for the discovery of natural toxins. The potential of conoidean 
toxins has been realized with the distribution of the first Conus (cone snail) drug, Prialt 
(ziconotide), an analgesic used to alleviate chronic pain in HIV and cancer patients. Cone 
snail toxins (conotoxins) are highly variable, a consequence of a high mutation rate associated 
to duplication events and positive selection.  As Conus and terebrids diverged in the early 
Paleocene, the toxins from terebrids (teretoxins) may demonstrate highly divergent and 
unique functionalities. Recent analysis of the Terebridae, a largely distributed family with 
more than 300 described species, indicate they have evolutionary and pharmacological 
potential. Based on a three gene, COI, 12S and 16S, molecular phylogeny, including ~50 
species from the Indo-Pacific, five main terebrid lineages were discriminated: Two of these 
lineages independently lost their venom apparatus, and one venomous lineage was previously 
unknown. Knowing the phylogenetic relationship of the Terebridae aids in effectively 
targeting divergent lineages with novel toxins. Preliminary results indicate that teretoxins are 
similar in structure and composition to conotoxins, suggesting teretoxins are an attractive line 
of research to discover and develop new therapeutics that target ion channels and receptors. 
Using conotoxins as a guideline, and innovative natural products discovery strategies, such as 
the Concerted Discovery Strategy, the potential of the Terebridae and their toxins are 
explored as a pioneering pharmacological resource.  
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Introduction 
 The conoideans (cone snails, terebrids, and turrids) are a hyperdiverse group of marine 
gastropods that prey on fish, worms, and other mollusks (Fig. 1). Several conoidean lineages 
are characterized by specialized organs referred to as a venom apparatus that is used to subdue 
prey [1]. Analysis over the last three decades of venom toxins produced by various species in 
the genus Conus, the most famous representative of this group, reveal a complex system of 
molecular compounds (see e.g. [2] [3] [4]). Each Conus species is able to produce 100-200 
peptide toxins [3, 5], making this genus, and by extension the whole Conoidea superfamily, 
one of the most promising groups for the discovery of natural peptide toxins together with 
snakes, spiders and scorpions. 
 Within the conoideans, the auger snails, or the Terebridae, include approximately 300 
to 350 described species [6, 7]. The Terebridae, characterized by an elongated shell, are 
mostly sand-dwellers that live in shallow-waters near the tropics. Contrary to cone snails, 
terebrids have not attracted significant scientific attention, and, comparatively little is known 
about their ecology and toxinology. Most of the main lineages of conoideans, including 
terebrids and conids, diverged at least in the early Paleocene [8]. Such an early separation 
would indicate toxins from terebrids could be highly divergent and unique, compare to toxins 
found in the genus Conus. 
 Presented here is an overview of the emerging potential of terebrids and their peptide 
toxins. As terebrid toxins are closely related to cone snail toxins (conotoxins), what is known 
about the structural and functional diversity of conotoxins, and their application in 
pharmacology is first briefly reviewed. In addition, a comparison will be made of the 
traditional biochemical approach to peptide toxin discovery, and a novel multidisciplinary 
biodiversity first approach, termed the Concerted Discovery Strategy (CDS), that combines 
molecular and chemical techniques with the phylogenetic analysis of species and toxin 
evolution to enhance the discovery of new natural products in the Terebridae. Recent results 
highlight the advantage of CDS to quickly define independent lineages within Conus [9, 10] 
and the terebrids [11, 12], thus facilitating the identification of numerous and divergent 
species, each producing unique toxins. By analogy with “conotoxin”, the term “teretoxin” is 
introduced to designate natural peptide toxins produced by terebrid snails. 
 
1. Conotoxins and pharmacology 
1.1. Brief history of the discovery of the first conotoxins 
 Cone snails were known as venomous predators [13] for many years before the 
analysis of their venom started in the 1970’s, with the isolation of active compounds from the 
venom gland of C. californicus [14] or C. geographus [15]. In 1981, Gray et al.[16] first 
biochemically described the structure and function of several conotoxins extracted from C. 
geographus. Soon after, the Olivera group identified numerous toxins from other Conus 
species, such as C. magus, C. striatus, and C. textile [17] [18] [19] [20]. In the following two 
decades, the regularity of toxin discovery has been enhanced both by the number of 
laboratories working on conotoxins, and by the use of new techniques that improved 
characterization methods such as molecular biology, HPLC, and sequencing. Currently there 
are more than 3,000 different proteins extracted from Conus venom described (Conoserver: 
http://research1t.imb.uq.edu.au/conoserver/). 
 
1. 2. Structure and function of conotoxins 
 The vast majority of conotoxins are characterized by a three-domain structure 
consisting of: a highly conserved signal sequence, a more variable pro-region and a 
hypervariable mature sequence (Fig. 2A). The signal sequence can be used as a diagnostic 
character to attribute each conotoxin to one of the ~15 superfamilies described so far (Fig 
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2B). The mature toxin is a cysteine-rich peptide with a highly conserved Cys pattern in each 
superfamily [3] (Fig. 3). At least 25 different functions have been described for a small 
fraction of the known conotoxins that have been functionally characterized ([3]; conoserver). 
By the end of the 1990’s, given the diversity of their molecular targets such as, sodium (Na+), 
potassium (K+) or calcium (Ca2+) channels, noradrenaline transporter, and nicotinic 
acetylcholine (nACh) receptors, it became apparent conotoxins possessed potentially 
numerous therapeutic applications.  
 
1.3 The emergence of conotoxins for drug development 
 The first conotoxin to be approved for use as a drug is ziconotide (Prialt), which is 
used to treat chronic pain in HIV and Cancer patients [21]. Ziconotide was discovered and 
developed from the ω-MVIIA peptide expressed by Conus magus (Fig. 3). As other ω 
conopeptides of the O superfamily, MVIIA targets Ca channels and has high specificity for 
the N-type calcium channel CaV2.2. The emergence of ziconotide has led to the increased 
investigation of cone snail peptides in drug development. This is in large part due to 
conotoxins effective specificity on ion channels and receptors. In a recent review Olivera [3], 
Table 1 listed several conotoxin-derived peptides that reached clinical development at various 
stages. These include: Contulakin-G (neurotensin receptor), χ-MrIA (norepinephrine 
transporter), α-Vc1.1 (nicotinic receptors), Conantokin-G (NMDA receptors), κ-PVIIA (K+ 
channels), and μO-MrVIB (Na+ channels).  Most of the contoxins listed are potential 
therapeutics for pain, but several are being evaluated for epilepsy or myocardial infarction. 
Twede et al. [22] also cited several other conotoxins with neuroprotective/cardioprotective 
properties: namely, conantokins, ω, μ and κ-conotoxins that respectively target NMDA 
receptors, Ca2+, Na+ and K+ channels. It should be noted that although ziconotide is a 
breakthrough, delivery of the drug by intrathecal injection is problematic and limits its utility. 
 
2. Conus: the tree that hides the forest 
2.1. Conoidean phylogeny 
 Conus and the Terebridae both belong to the superfamily Conoidea. This group has 
always been considered a taxonomic nightmare, primarily because of its substantial diversity, 
4,000 described species, with an estimate of more than 10,000 living species [23], and 
secondarily because of the difficulty to propose a stable system of classification [24]. Very 
few classifications have been proposed, however most of them are not congruent, and are 
largely contradictory. Conoidean classification has evolved in accordance with the character 
type used to delimit groups. Initially, only shell and radula characters were used. As they are 
beautifully ornamented and easily distinguished, cone snails are the most famous conoideans, 
a star among shell collectors, taxonomists, and biochemists alike. Consequently, cone snails 
were classified in a separate family, the Conidae. Similarly, the Terebridae, with their thin, 
elongated shells, are relatively easy to recognize, and were also classified as an independent 
family. All the others conoideans were placed in the Turridae s.l. (Fig. 1A). More recently, the 
analysis of anatomical characters revealed that cone snails are not so different from other 
conoideans, and some turrids (Clathurellinae, Raphitominae, Mangeliinae, Oenopotinae, 
Conorbinae) were placed in the Conidae together with Conus ([1]; Fig. 1B). The use of 
molecular characters to analyze conoidean classification gave yet a different structure to the 
superfamily. Molecular characters confirmed that Turridae s.l. was a largely paraphyletic 
group, including Conus, but also potentially Terebridae [24]. It is clear that more 
interdisciplinary research that combines molecular, anatomical and morphological characters 
is needed to establish a valid classification of the Conoidea. 
 
2.2. The revolution of molecular phylogeny as it pertains to conoideans 
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 The advent of the polymerase chain reaction (PCR) and sequencing has revolutionized 
taxonomic classification. Together with anatomical and morphological characters, molecular 
approaches help to define distinct biodiverse groups. Molecular approaches identified at least 
15 independent lineages within the conoideans, most of them corresponding to previously 
recognized taxa [1, 8, 24, 25]. Some taxa were traditionally recognized as families, i.e. Conus 
as Conidae, while others were considered as subfamilies, i.e. Mangeliinae, and Crassispirinae. 
Molecular results suggest that the genus Conus does not have a central position in the 
superfamily, but rather it corresponds to one lineage among others. Even if cone snails remain 
the most collected and studied group within conoideans, terebrids and turrids are a compelling 
research source as they may have evolved unique and diverse venom toxins. Preliminary 
analyzes of turritoxins [26, 27] and teretoxins [28, 29] are promising (Table 1). 
 Consider for a moment, if 3,000 conotoxins are already described, how many peptide 
toxins can be expected for the whole conoideans? How can such diversity be embraced, and 
how can toxin discovery be optimized? In the next two sections, an estimation of toxin 
diversity is proposed to answer the first question, and a new strategy, termed “Concerted 
Discovery Strategy (CDS),” is described to handle the second. 
 
2.3. A sizeable natural library of peptide toxins 
 It has been shown that each Conus species can express between 100 and 200 different 
peptide toxins, most being exclusive, i.e. not found in any other species. With more than 600 
described species, and others remaining to be discovered, it can estimated that 60,000 to 
120,000 different toxins could be produced by cone snails. These numbers are probably 
underestimated, as unpublished results (F. Ducancel et al., A. Lluisma and P. 
Bandyopadhyay) indicate that a single species may include 200 different toxins, only for the 
A-superfamily. Preliminary results obtained for terebrids and turrids seem to indicate that 
similar levels of toxin diversity occur in these two groups as well [26-31] (Fig. 4). Based on 
these conclusions, it is possible to estimate that the whole Conoidean superfamily could 
contain between 400,000 and 2,000,000 different toxins. Spiders are the only other venomous 
group thought to include similar levels of toxin diversity [32]. Conoideans are thus producing 
a sizeable natural library of peptide toxins that have potential applications for drug 
development. 
 
2.4. A concerted discovery strategy for finding new peptide toxins 
 As applied since the beginning of the 1980’s, the traditional process of toxin discovery 
is to fractionate the crude venom from a target species, then characterize the fractions using 
Edman sequencing or electrospray ionization mass spectrometry (ESI-MS/MS) (Fig. 5A). 
Most of the species that have been studied with this method correspond to species that are 
easy to collect, large enough to allow an easy extraction of the venom in a sufficient quantity, 
and known to be highly venomous, especially for vertebrate preys. These features were 
thought to indicate toxins viable for therapeutic applications in humans. While overwhelming 
used by most researchers, the traditional strategy has several drawbacks, such as it is 
extremely laborious and requires large amounts of material to be successful. Several findings 
from the work of the Olivera group [33, 34] in the 1990’s elucidated the molecular structure 
of conotoxins (Fig. 2). Namely, the conserved signaling region of the gene superfamilies, has 
enabled the use of PCR and other molecular techniques to minimize the identification of 
toxins using the traditional strategy. However, in cases where a significant amount of sample 
material is not available, use of the traditional strategy is a challenge.  
 The Concerted Discovery Strategy (CDS), previously referred to as the exogenomic 
strategy as proposed by Olivera [3], differs from the traditional toxin discovery strategy in the 
way species and venom compounds are selected (Fig. 5B). With CDS, species are not chosen 
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based on technical criteria, such as size and ease of collection, but using an evolutionary-
based approach. The central idea is to identify species that belong to highly divergent 
lineages, thus potentially able to express highly divergent toxins. This method enhances the 
probability of characterizing different toxins. A larger pool of different toxins increases the 
likelihood of identifying those with different molecular targets, indicating different 
therapeutic applications. Compared to the traditional strategy, where most of the studied 
species belonged to a limited number of clades within Conus, suggesting a biased estimation 
of the peptide toxin diversity within the genus, CDS is much more aligned with identifying a 
diverse set of peptide toxins with diverse functional applications. Furthermore, a biodiversity 
first concerted method will allow the identification of the lineages that have lost the venom 
apparatus within the conoideans, a not-so-rare feature in this group (see Sect. 4.2.2, but also 
[1, 35, 36]; Fedosov and Puillandre unpublished data). A priori knowledge about the presence 
or absence of a venom apparatus eliminates the expense of time and resources pursuing 
specimens without venom ducts, hence not expressing peptide toxins to hunt prey. 
Another feature of CDS makes use of the advances of molecular biology in the form 
of manufacturing cDNA or EST libraries. Using cDNA libraries of venom duct tissue, 
expressed gene products are analyzed, and potential toxin peptides are identified. At this 
stage, a phylogenetic approach can be used to analyze the toxin diversity within a single 
species. Recent studies have shown that divergent clade within a toxin-based phylogeny may 
produce toxins with different functions (e.g. [2, 9, 10]; Puillandre et al. in press). Instead of 
functionally analyzing randomly-chosen toxins, as in the traditional method, CDS highlights 
promising toxins to be screened first. Using CDS, phylogenetic methods are used to identify 
prospective targets, first species within conoideans and then toxins within the selected 
species. 
 
3. The Terebridae family 
3.1. Traditional taxonomy of the Terebridae 
The Terebridae was first identified and classified by Bruguiere (1789), who created the 
genus Terebra. Since that time the seminal works to classify the group have been presented in 
recent papers highlighting the anatomy and shell morphology [7, 37-39]. Miller in his 
publications in the 1970’s plucked the group from relative obscurity to highlight the 
fascinating degree of anatomical variability that accounts for the diverse feeding strategies 
within the Terebridae. Based on analysis of foregut materials Miller identified three different 
types of terebrid anatomy: Type I has salivary glands, a shrunken buccal tube, no radula sac, 
venom duct, or venom bulb. Type II has the venom apparatus similar to Conus, i.e. a radular 
sac, venom duct and venom bulb, in addition to salivary glands and a true proboscis. Type III, 
lacks salivary glands and the components of the venom apparatus, but has an uncharacteristic 
accessory feeding organ, the accessory proboscis structure. Using specimens from the genera 
Duplicaria, Taylor has revised terebrid foregut anatomy based on radula characteristics and 
identified an amenndum to Miller’s Type I that has salivary glands and a radula sac, but no 
venom gland [38]. Based on shell morphology, Bratcher and Cernohorsky [7], and more 
recently Terryn [6] have identified ~300 different species within the Terebridae. Bratcher and 
Cernohorsky placed the species into four genera: a large genus termed Terebra, consisting of 
the majority of species, a second genus termed Hastula, a third genus termed Duplicaria, and 
a fourth termed Terenolla. Terryn in his classification made use of ~15 genera terms, 
including Myurella, and Cinguloterebra. The first phylogeny of the group was done by Taylor 
et al. [1]. Using seven species of Terebrinae and seven of Pervicaciinae, Taylor and 
colleagues outlined anatomical terminology for the terebrid foregut and postulated a 
phylogeny that identified the Terebridae as monophyletic and separate from the Coninae. 
Simone in 2000 [40] updated the terebrid phylogeny using specimens from the Western 
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Atlantic. Simone confirmed the monophyly of the group, identified the Hastula genera as 
separate from the genus Terebra and found the following apomorphies: reduction of the 
cephalic tentacles, anterior end of the ctenidial vein prominent (without gill filaments), 
rhynchodcal introvert, and anus situated very posteriorly in the pallial cavity. Bouchet and 
Rocroi [41] in the most recent classification based on morphology of the Gastropoda 
confirmed the presence of two subfamilies, Terebrinae and Pervicaciinae, within the family 
Terebridae. The use of anatomy, and shell characteristics were sufficient to elucidate the 
monophly of the Terebridae, but for definitive delimitations at genera and species level, an 
integrative approach using molecular biology is required.  
 
3.2. Molecular Phylogeny applied to the Terebridae  
The revisionary process that resulted from the use of molecular characters for the 
conoidean classification also happened for the Terebridae. Most of the genera recognized by 
Terryn [6] do not correspond to clades, as defined by molecular analyzes based on three 
mitochondrial genes and ~50 different species [11, 12]. Molecular analysis identified 5 
distinct clades in the Terebridae: a sister group to all other terebrids made up of T. jungi, since 
revised to the genus Pellifronia [42] (Clade A), an Acus clade (Clade B), a Terebra clade 
(Clade C), a Hastula clade (Clade D), and a Myurella clade (Clade E) (Fig. 6). This result 
indicates that most of the morphological characters used to define genus-level groups of 
terebrids should be used with caution, and could correspond to convergent evolution or 
ancestral polymorphism. The genus “Terebra” is a good illustration of the conflict between 
classical morphological characters and molecular data. Specimens morphologically attributed 
to this genus are found in three different clades: Pellifronia (Clade A), Terebra (Clade C), and 
Myurella (Clade E) as identified by Holford et al. [11, 12].  
In addition to the clarification of the phylogenetic relationships within the Terebridae, 
the tree outlined in Figure 6 provides a reliable framework to analyze the evolution of 
different characters (see Sect. 4). 
 
3.3. Alpha-taxonomy of the Terebridae 
As stated above, the only available molecular work on terebrids highlighted several 
complications at the generic level, and also revealed that the alpha-taxonomy (species 
delimitation and description) may need to be revised [12]. Based on shell characters only, the 
definition of species in the Terebridae certainly suffers from the same pitfalls cited previously 
for the classification: morphological convergence or ancestral polymorphism. Furthermore, 
the molluscan shell is known to be highly plastic, and morphological variation may only be 
the results of environmental variability within a single species range [43]. The results 
presented in Holford et al. [12] indicate that some species correspond to several lineages (e.g. 
Strioterebrum plumbeum, Cinguloterebra fenestrata), and that several molecularly defined 
lineages are not named at the species level (e.g. the “Terebra” textilis complex). However, the 
sampling used in this study does not allow a clear analysis of the species-level variability 
within the terebrids. More specimens are required to estimate both the intra and inter-specific 
variability of each putative species, in order to propose robust hypotheses of species 
delimitation. 
Several recent expeditions carried out in the Indo-Pacific by the Muséum National 
d’Histoire Naturelle (Paris) uncovered a large number of specimens, representing both already 
described species and several unknown taxa. Recently, four different Terebridae species were 
collected during an expedition in the East Pacific (Panama) [11]. Two of these four species 
were represented by several specimens, and the results are congruent with the morphological 
hypotheses: the molecular variability within species is weaker than the variability between 
species. 
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3.4 Terebrid ecology and behavior 
Miller [44] provided the most detail known to date on the feeding ecology of the 
terebrids. Miller described three anatomical feeding varieties (Types I, II, and III) only one of 
which (Type II) possessed the venom apparatus similar to that used by Conus. The terebrid 
clades that have a venom apparatus correspond to three divergent lineages, implying the three 
clades with venom apparatus (Pellifronia, Terebra, and Hastula) may have evolved different 
feeding strategy (Fig. 6). Furthermore, if the two other terebrid lineages that have lost the 
venom duct, Types I and III, are not good candidates to find new teretoxins, they are good 
models to analyze the ecological adaptation of venom-apparatus free conoideans. Questions 
such as, how do species that lack the venom duct and radula, which are the main 
characteristics for capturing prey using venom toxins, feed? Are they still able to capture prey 
using toxins produced by other glands (e.g. the salivary gland), or did they develop new 
strategies not based on venom? If so, did the two lineages without the venom ducts develop 
similar or different strategies? Preliminary work in Conus has demonstrated that toxins are 
produced in the salivary glands [45], suggesting it may be possible that the Type I species of 
terebrid that lack a venom apparatus, but have salivary glands, could also use toxins to subdue 
its prey. The delivery of the toxins is not clear as most Type I species do not have a radular or 
a true proboscis to deliver the toxin to the prey. Type III terebrids have developed an 
accessory feeding organ that they use to engulf polychaetes and other worms. 
There are many open questions pertaining to the ecology of the terebrids. These could 
be addressed in tandem with studies involving the evolutionary development of the venom 
apparatus. Of the three Miller types which is the ancestral one that led to the development of 
the others? The radula is often hailed as the component responsible for the radiation of species 
diversity in Conus [46], could it also explain diversity in Type II terebrids? Given the 
complications of breeding terebrids and the complexity of the venom apparatus, evolutionary 
development questions might be difficult to approach using embryology and current evo-devo 
techniques, but highlight an interesting line of research that would enhance current knowledge 
about the terebridae and evolutionary/ecological development in general. 
 
3.5 Evolution of venom apparatus as it pertains to peptide toxins in the Terebridae 
One striking result of the molecular phylogenetic analysis of the Terebridae is that the 
venom apparatus appears to have been lost at least twice independently during the evolution 
of the group (Fig. 6). The loss of venom duct in the family enables the study of evolutionary 
development of the venom apparatus in the Terebridae that may yield clues to the whole 
Conoidea Superfamily. 
The corollary result is that the venom duct was certainly already present in the 
common ancestor of all the terebrids, and also in the common ancestor of all the conoideans 
[1]. From this common ancestor, three highly divergent lineages evolved independently in the 
Terebridae, Pellifronia, Terebra and Hastula. As these lineages correspond to deep nodes in 
the tree, and given the extremely high rate of evolution of the toxins in the genus Conus [2, 4], 
these terebrids may have evolved different toxins. The conotoxins discovered so far belong to 
~ 15 different superfamilies, and evolved ~ 25 different functions; however, the genetic 
distance between Pellifronia, Terebra and Hastula within the Terebridae is at least two times 
greater than the distance between the different species of Conus from which the known 
conotoxins were extracted (unpublished results). The potential divergence between teretoxins 
extracted from species belonging to different clades suggests previously undescribed 
superfamilies and functions could be identified from terebrid characterizations. 
 
3.6 Preliminary characterization of teretoxins 
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 While only a few teretoxins have been described in the literature, their preliminary 
characterization indicate their potential as biochemical tools for analyzing the mechanics and 
function of the neuronal circuit. Several teretoxins, previously referred to as augertoxins, 
identified by Imperial and colleagues [28, 29] from Terebra subulata and Hastula hectica 
have a cysteine framework similar to the O superfamily of conotoxins (Table 1). This 
suggests that they may fold into to the inhibitory cysteine knot motif referred to as the ICK 
motif [52]. The ICK motif is common among peptide toxins from various organisms 
including snakes and spiders, and is known to block ion channels. While the T. subulata 
teretoxins identified by Imperial and colleagues have a similar O-superfamily cysetine 
framework, the signal sequence of the precursor region is not homologous with the conotoxin 
O superfamily signal sequence [28]. This suggests that although the mature toxins are similar, 
the genes encoding the peptides are not. Likewise, the teretoxins identified from H. hectica 
[29] have cysteine patterns similar to the O and P conotoxin superfamilies, but their signal 
sequences are highly divergent. Indicating the genetic makeup of conus and terebrid toxins 
are not the same. It thus follows that newly discovered teretoxins could have diverse 
functional applications compared to their conotoxin counterparts. 
 
4. Taxonomy as a tool for drug discovery  
4.1. Congruence between anatomy and molecular phylogeny 
 The strong congruence between anatomy and the molecular phylogeny based on 
Western Pacific species is shown in Fig. 6.  All the species included in the Acus (clade B) and 
Myurella (clade E) do not have a venom apparatus, therefore not using peptide toxins to hunt 
prey. Conversely, all the species included in the three other clades, Pellifronia (A), Terebra 
(C) and Hastula (D) all have the venom apparatus, as confirmed by the anatomical dissection 
of most of the species included in the dataset [12]. The correlation between anatomy and 
molecular phylogeny was confirmed by the inclusion of several species collected in the 
Eastern Pacific. The Panamic species A. strigata, placed in the Acus clade, does not have a 
venom apparatus, while three other Panamic species, T. argyosia, T. ornata, and T. formosa, 
which possess a venom apparatus, are placed in the Terebra clade [11]. These results support 
the premise that the presence or absence of the venom duct can be inferred by including a 
given species in the phylogenetic tree, without dissecting it. From a teretoxin discovery 
perspective, the phylogenetic tree would then be an invaluable asset, capable of readily 
identifying the lineages with a venom apparatus and expressing peptide toxins for predation. 
In addition, the phylogenetic tree could be used to identify divergent lineages and enhance 
teretoxin discovery as outlined in Sect. 2.4. Analysis of at least one species from each clade 
with a venom apparatus would be sufficient to provide a gross estimation of the toxin 
diversity of terebrids. 
 
4.2. The importance of a complete Terebridae phylogeny for drug discovery 
The current molecular phylogeny of the Terebridae [11] is not comprehensive. Several 
genera and biogeographic regions are not represented in the dataset. As five lineages are 
present in the Indo-Pacific, two of them having lost the venom apparatus, it can be expect that 
there are additional lineages in other regions that have evolved distinct toxins and possible 
other independent lineages that have lost the venom apparatus. A complete terebrid phylogeny 
would greatly enhance the discovery and characterization of novel teretoxins. Current studies 
are under way to sample more of the Eastern Pacific and other regions to encounter the 
missing taxa. 
The Concerted Discovery Strategy (CDS) as initially described [3] and expanded upon 
by Olivera and Teichert [9] using α-conotoxins as a model, demonstrates the importance of 
understanding the phylogeny of the Conoidea when targeting novel bioactive compounds. 
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Paramount to the strategy is the fact that the genes that encode venom toxins are rapidly 
evolving, to reflect changes in ecological niches. This ebb and flow between genes and the 
surrounding environment results in a diversification of toxins. One of the keys to 
understanding this diversifying selection process is to reliable reconstruct the phylogeny of 
the group and use it as a roadmap for peptide toxin discovery.  
 
5. Summary and Conclusion 
 The Terebridae are a promising family within the Conoidea. Similar to cone snails 
terebrids possess venom peptide toxins that appear rich in variety and functional applications 
(Table 1). Preliminary results conducting biochemical [28] and molecular [29] 
characterization of teretoxins indicate they are very similar in structure to cone snail toxins. 
Teretoxins thus far identified appear to be larger than conotoxins (> 40 amino acids) and do 
not have posttranslation modifications, a feature commonly found in conotoxins. The lack of 
posttranslation modifications makes teretoxins an attractive target for analysis using mass 
spectrometry. Recently Ueberheide and colleagues [48] developed a mass spectrometry 
approach for elucidating toxin sequences from cone snails that utilizes the electron-transfer 
dissociation (ETD) method for tandem mass spectrometry. ETD is used to increase sequence 
coverage and improve mass detection to limits well beyond those of Edman sequencing and 
previous mass spectrometry methods. While limited by the current high cost of advanced 
mass spectrometry hardware, this technique appears to be a viable complement to the 
Concerted Discovery Strategy (CDS), and can be used both to confirm the expression and 
characterization of newly discovered teretoxins. While thus far applied only to reduced toxin 
compounds, the charge enhanced ETD inspired method also holds promise for confirming the 
disulfide bonding patterns when applied to peptide toxins in the native conformation. In 
addition, recombinant techniques such as the recently described tethered-toxin approach [47, 
49-51] facilitate the synthesis and folding of larger peptidic toxins.  
Several teretoxins identified by Imperial and colleagues [28, 29] from Terebra 
subulata and Hastula hectica have a cysteine framework similar to the O superfamily of 
conotoxins. This suggests that they may fold into to the inhibitory cysteine knot motif referred 
to as the ICK motif [52]. The ICK motif is common among peptide toxins from various 
organisms including snakes and spiders, and is known to block ion channels. Although not 
traditionally the molecular compound of choice for drug discovery, peptides, and especially 
peptidic toxins, are becoming increasing important in the development of novel drug 
discovery pipelines. The N-type calcium (Ca2+) channel analgesic ziconotide, the first 
conotoxin drug, is striking for the molecular target and function combination it identified [21]. 
Prior to ziconotide’s discovery Ca2+ channels were not readily recognized as targets for pain 
alleviation. Similar to Ziconotide, an ω conotoxin, several other conotoxin families including, 
μ-conotoxins that target voltage-gated Na+ channels, k- and kM-conotoxins that target K+ 
channels, and conantokins that target NMDA receptors are under various stages of 
pharmaceutical development [3, 22, 53]. The potential applications of these conotoxins vary 
from pain, to epilepsy, and cardioprotective agents. In addition to conotoxins, peptidic toxins 
from scorpions, snakes and spiders, such as candoxin (Alzheimer’s disease) [54], and α-Bgtx 
(myasthenic autoimmune response) [55, 56] are making an impact in pharmacological 
developments. These peptides and the organisms that produce them are instrumental in 
identifying the next generation of therapeutics. 
It is noteworthy that the T. subulata teretoxins identified by Imperial and colleagues 
have a similar O-superfamily Cysetine framework, however, the signal sequence of the 
precursor region is not homologous with the conotoxin O superfamily signal sequence [28]. 
This suggests that although the mature toxins are similar, the genes encoding the peptides are 
not. Likewise, the teretoxins identified from H. hectica [29] have cysteine patterns similar to 
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the A and P conotoxin superfamilies, but their signal sequences are highly divergent; again 
suggesting the genetic makeup of the conus and terebrid toxins are not the same. It thus 
follows that newly discovered teretoxins could have radically diverse functional applications 
compared to their conotoxin counterparts. A discovery strategy such as CDS, which takes into 
account the divergent characteristic of peptide toxins from biodiverse organisms, paired 
together with current advances in peptide/proteomics, genomic and bioinformatic 
technologies not only highlights pharmacologically useful bioactive compounds, but also 
provides a paradigm for investigating peptidic natural products. Current integrative initiatives 
that utilize ecological, genomic, proteomic, and functional activity based data of toxins, such 
as the cone snail genome project for health, CONCO (www.conco.eu), and Venomics [57], 
will be useful in deciphering the potential and challenges ahead for terebrid toxin 
characterization. 
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Table 1: Recently identified teretoxins. 
 
 
 
Figure legends: 
 
Figure 1: Evolution of Conoidea classification. Cone snail, turrid, and terebrid shells that 
make up the Conoidean superfamily are depicted. A. Conoidea classification based on shell 
and radula characters (e.g. [8, 58]). B. Conodiea classification based mainly on anatomical 
characters ([1]). ST = Strictispiridae; DR = Drilliidae; PS = Pseudomelatomidae. C. 
Conoidea classification with molecular characters. Two main clades are defined, but a formal 
classification has not yet been proposed. 
 
Figure 2: Molecular organization of Conoidean venom toxins. A. Schematic of the 
precursor sequence for conoidean toxins. Conoidean toxins possess a signal sequence at the n-
termini, an intervening pro-region, followed by the mature toxin in single copy. Each gene 
superfamily is generally characterized by one highly conserved signal sequence, associated in 
most cases to one cysteine (Cys)-pattern in the mature sequence, and corresponding to several 
toxin families (such as α, µ, ω, δ) and molecular targets (ion channels or receptors). B. 
Conotoxin examples. Depicted are the mature toxin sequences, gene superfamily, and 
molecular targets of well characterized conotoxins. 
 
Figure 3:  Cysteine scaffold of conotoxins. Representative disulfide connectivity of three 
conotoxins belonging to three different gene superfamilies are illustrated. 
 
Figure 4: Comparison of the known number of toxins (left) and species (right) in the 
main groups of the Conoidea. The number of toxins in Conidae (“conotoxins”) corresponds 
to the published toxins in GenBank. No turritoxins or teretoxins are published in GenBank, 
but several were recently described ([26-31]). 
 
Figure 5: Toxin discovery process. A. Traditional strategy. Analyzed species are chosen 
randomly, and may correspond to a single lineage. Prospective toxin analysis starts first with 
characterization of venom components by HPLC (venom fractionation). B. Concerted 
Discovery Strategy (CDS). Taxonomic tools are used first to identify independent lineages to 
maximize the species, and thus teretoxin diversity, and then to analyze the numerous cDNA 
compounds isolated from each analyzed specimen.  Application of CDS increases discovery 
of divergent teretoxins. 
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Figure 6: Molecular phylogeny of the Terebridae. Five clades are defined Pellifronia, 
Acus, Terebra, Hastula, and Myurella (Clades A to E). Two clades have lost the venom 
apparatus: Acus (clade B) and Myurella (clade E), corresponding to two independent losses 
(red stars). Two lineages are found in the Panamic Eastern Pacific, black arrows correspond to 
Acus strigata and Terebra arygosia, the others in the Western Pacific. The tree was 
constructed using Bayesian and likelihood analyzes based on COI, 12S and 16S mitochondrial 
genes, see [11, 12] for full details on the molecular phylogeny. The molecular phylogeny of 
the Terebridae effectively highlights the terebrid lineages that have a venom apparatus 
(Pellifronia, Terebra, Hastula), therefore using peptide toxins to subdue prey, and those that 
do not have a venom apparatus (Acus, Myurella), thus not using toxins to hunt.  
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